Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Fletcher

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
The American Journal of Gastroenterology|February 1, 1990
Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with SandostatinE J Mozell, E A Woltering, T M O'Dorisio, et al.
Medical and Pediatric Oncology|January 1, 1988
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group StudyC B Vaughn, S J Green, R O'Bryan, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, S J Green, et al.
American Journal of Clinical Oncology|April 1, 1996
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)L E Flaherty, P Y Liu, M S Mitchell, et al.
Journal of Surgical Oncology|January 1, 1979
Combination chemotherapy for soft-tissue sarcomas: a phase III studyA B Cruz, E A Thames, J B Aust, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of 5-azacytidine in solid tumorsA J Weiss, G E Metter, T F Nealon, et al.
Surgery, Gynecology & Obstetrics|June 1, 1976
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?G J Hill, R O Johnson, G Metter, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Journal of Surgical Oncology|January 1, 1978
Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333)J P Scarborough, G E Metter, H Stephens Moseley, et al.
Cancer|November 15, 1984
Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group studyB Hoogstraten, N Gad-el-Mawla, T R Maloney, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The American Journal of Gastroenterology|February 1, 1990
Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with SandostatinE J Mozell, E A Woltering, T M O'Dorisio, et al.
Medical and Pediatric Oncology|January 1, 1988
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group StudyC B Vaughn, S J Green, R O'Bryan, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, S J Green, et al.
American Journal of Clinical Oncology|April 1, 1996
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)L E Flaherty, P Y Liu, M S Mitchell, et al.
Journal of Surgical Oncology|January 1, 1979
Combination chemotherapy for soft-tissue sarcomas: a phase III studyA B Cruz, E A Thames, J B Aust, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of 5-azacytidine in solid tumorsA J Weiss, G E Metter, T F Nealon, et al.
Surgery, Gynecology & Obstetrics|June 1, 1976
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?G J Hill, R O Johnson, G Metter, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Journal of Surgical Oncology|January 1, 1978
Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333)J P Scarborough, G E Metter, H Stephens Moseley, et al.
Cancer|November 15, 1984
Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group studyB Hoogstraten, N Gad-el-Mawla, T R Maloney, et al.
Pageof 11